Peter MacCallum Cancer

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Mantle cell lymphoma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Daiichi Sankyo1 trial
• Pharmacyclics LLC.1 trial

Closed trials

• Completed

  DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

  NCT03529110· Phase 3· Daiichi Sankyo· Source

• Completed

  Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

  NCT03112174· Phase 3· Pharmacyclics LLC.· Source